NeuroSense Therapeutics Ltd. (NRSN) Financials
NRSN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 1.0 million | 2.6 million |
| June 30, 2025 | 1.7 million | 2.2 million |
| March 31, 2025 | 1.7 million | 2.2 million |
| Dec. 31, 2024 | 4.6 million | 2.0 million |
NRSN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | ? | ? |
| June 30, 2025 | -2000 | 153 |
| March 31, 2025 | -2000 | 153 |
| Dec. 31, 2024 | ? | 557 |
NRSN Net Income
No data available :(
NRSN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 166000 | - | 170000 |
| June 30, 2025 | 666000 | - | - |
| March 31, 2025 | 666000 | - | - |
| Dec. 31, 2024 | 3.4 million | - | 73000 |
NRSN Shares Outstanding
NRSN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | - | - | - |
| June 30, 2025 | - | 1.3 million | 1.1 million | - |
| March 31, 2025 | - | 1.3 million | 1.1 million | - |
| Dec. 31, 2024 | - | 1.1 million | 685000 | - |
NRSN Cost of Revenue
No data available :(
NRSN
Price: $0.70
52 week price:
Earnings Per Share: -0.44 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 108700
Market Capitalization: 17.5 million